Syphilis Immunoassay Diagnostics Market Report 2026

Syphilis Immunoassay Diagnostics Market Overview

• Syphilis Immunoassay Diagnostics market size has reached to $33.5 billion in 2025 • Expected to grow to $46.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Sexually Transmitted Diseases Boosting Syphilis Immunoassay Diagnostics Market • Market Trend: Advancements In Rapid Syphilis Immunoassay Diagnostics • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Syphilis Immunoassay Diagnostics Market?

Syphilis immunoassay diagnostics refer to laboratory tests used to detect the presence of antibodies or antigens related to the bacterium treponema pallidum, which causes syphilis. These diagnostics employ immunoassay techniques to identify specific immune responses in the blood. The primary aim of syphilis immunoassay diagnostics is to diagnose syphilis infections, enabling timely and effective treatment accurately. The main types of products in syphilis immunoassay diagnostics are analyzers, reagents, kits, and others. Analyzers are devices used in laboratories to measure and analyze the presence of syphilis in a sample. The various technologies involved chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), and others. These diagnostics are used for men and women applications by different end-users including hospitals, blood banks, diagnostics labs, and others.

What Is The Syphilis Immunoassay Diagnostics Market Growth Forecast?

The syphilis immunoassay diagnostics market size is expected to see strong growth in the next few years. It will grow to $46.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing adoption of rapid diagnostic tests, rising focus on decentralized testing models, expansion of screening in developing regions, growing investments in laboratory automation, increasing demand for high-throughput diagnostic platforms. Major trends in the forecast period include increasing adoption of automated immunoassay analyzers, rising demand for high-sensitivity diagnostic kits, expansion of point-of-care syphilis testing, growing integration of digital laboratory workflows, enhanced focus on early and accurate disease detection.

Global Syphilis Immunoassay Diagnostics Market Segmentation

1) By Product: Analyzers, Reagents, Kits, Other Products 2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies 3) By Application: Men, Women 4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users Subsegments: 1) By Analyzers: Automated Analyzers, Semi-Automated Analyzers, Manual Analyzers 2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents, Chemiluminescent Immunoassay Reagents, Rapid Plasma Reagin Reagents, Treponemal And Non-Treponemal Reagents 3) By Kits: ELISA Kits, Rapid Diagnostic Test Kits, CLIA Kits, Point-Of-Care Test Kits 4) By Other Products: Control And Calibration Materials, Sample Collection Devices, Ancillary Testing Accessories

What Is The Driver Of The Syphilis Immunoassay Diagnostics Market?

The rise in sexually transmitted diseases is expected to propel the growth of the syphilis immunoassay diagnostics market going forward. Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections that are primarily spread through sexual contact. It includes vaginal, anal, and oral sex. The rise in sexually transmitted diseases is attributed to decreasing condom use, antibiotic resistance, lack of sexual education, social and behavioral changes, stigma, reduced funding for STD programs, and increased travel. Syphilis immunoassay diagnostics help in the detection and management of sexually transmitted diseases by providing accurate, timely identification of syphilis infection, enabling appropriate treatment and prevention measures. For instance, in June 2024, according to the report published by the Terrence Higgins Trust, a UK-based organisation, the UK Health Security Agency (UKHSA) showed there were 401,800 sexually transmitted infections (STIs) reported in England in 2023, a 5% rise on the previous year. Therefore, the rise in sexually transmitted diseases is driving the syphilis immunoassay diagnostics industry.

Key Players In The Global Syphilis Immunoassay Diagnostics Market

Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Meril Life Sciences Pvt Ltd, Randox Laboratories Ltd, SEKISUI Diagnostics, Trinity Biotech, Fujirebio, CTK Biotech Inc, bioLytical Laboratories Inc, ACON Laboratories Inc, InTec PRODUCTS INC, Quidel Corporation, Alere Inc, Ortho Clinical Diagnostics, DiaSorin Inc, Sekisui Medical, Beckman Coulter

Global Syphilis Immunoassay Diagnostics Market Trends and Insights

Major companies operating in the syphilis immunoassay diagnostics market are focused on developing innovative solutions, such as rapid syphilis tests, to enhance the efficiency and accuracy of syphilis detection. Rapid syphilis tests are simple, point-of-care tools that detect syphilis antibodies in blood or bodily fluids within minutes, enabling quick diagnosis and early treatment. For instance, in February 2023, Chembio Diagnostics Inc., a US-based point-of-care diagnostics company focused on infectious diseases, received a CLIA waiver from the FDA for its DPP HIV-Syphilis System. The DPP HIV-Syphilis System is a dual rapid test designed for the simultaneous detection of antibodies to HIV 1/2 and Treponema pallidum, the bacteria that causes syphilis. This rapid, 15-minute test aims to improve diagnosis and treatment, especially in preventing mother-to-child transmission of syphilis and reducing the risk of contracting HIV among those with syphilis.

What Are Latest Mergers And Acquisitions In The Syphilis Immunoassay Diagnostics Market?

In April 2023, Biosynex SA, a Frane-based company that offers syphilis immunoassay diagnostics, acquired Chembio Diagnostics, Inc. for $17.2 million. This acquisition enhances Biosynex's market presence in North America, leveraging Chembio's existing FDA-approved products and expertise in rapid diagnostic tests. Chembio Diagnostics Inc. is a US-based point-of-care diagnostics company focused on infectious diseases, including syphilis.

Regional Outlook

North America was the largest region in the syphilis immunoassay diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Syphilis Immunoassay Diagnostics Market?

The syphilis immunoassay diagnostics market consists of revenues earned by entities by providing services such as sample collection services, laboratory testing services, point-of-care testing services, and consultation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The syphilis immunoassay diagnostics market also consists of sales of rapid plasma reagin (RPR) tests, fluorescent treponemal antibody absorption (FTA-ABS) tests, point-of-care (POC) tests, western blot assays, and multiplex immunoassays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Syphilis Immunoassay Diagnostics Market Report 2026?

The syphilis immunoassay diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the syphilis immunoassay diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.